CN Stock MarketDetailed Quotes

Hunan Er-kang Pharmaceutical (300267)

Watchlist
  • 3.96
  • -0.19-4.58%
Market Closed Jan 16 15:00 CST
8.17BMarket Cap-26.58P/E (TTM)

Hunan Er-kang Pharmaceutical (300267) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Ingredients455.8M66.84%
New energy materials126.6M18.57%
Raw material medicine46.74M6.85%
Finished product medicine38.75M5.68%
Total special adjustments13.99M2.05%

By Industry

Currency:CNY
2025/H1
Stock NameRevenueRatio
Pharmaceutical industry541.29M79.38%
New energy industry126.6M18.57%
Other business7.58M1.11%
Total special adjustments6.41M0.94%

By Country/Region

Currency:CNY
2025/H1
Stock NameRevenueRatio
Overseas region169.83M24.91%
Central China151.84M22.27%
South China142.55M20.91%
East China region107.29M15.73%
Total special adjustments102.79M15.07%
Other business7.58M1.11%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
View More
Nancy Pelosi Portfolio
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More